These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


820 related items for PubMed ID: 10667595

  • 1. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, Redston M, Gallinger S.
    Cancer Res; 2000 Jan 15; 60(2):409-16. PubMed ID: 10667595
    [Abstract] [Full Text] [Related]

  • 2. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE, O'Reilly EM, Kelsen DP, Ashraf AM, Lowery MA, Yu KH, Reidy DL, Epstein AS, Lincoln A, Saldia A, Jacobs LM, Rau-Murthy R, Zhang L, Kurtz RC, Saltz L, Offit K, Robson ME, Stadler ZK.
    Cancer; 2015 Dec 15; 121(24):4382-8. PubMed ID: 26440929
    [Abstract] [Full Text] [Related]

  • 3. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA, Baig MK, Milewski B, Keywan C, Guarino M, Petrelli N.
    Ann Surg Oncol; 2016 May 15; 23(5):1729-35. PubMed ID: 26727920
    [Abstract] [Full Text] [Related]

  • 4. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.
    Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E.
    Br J Cancer; 2000 Aug 15; 83(4):463-6. PubMed ID: 10945492
    [Abstract] [Full Text] [Related]

  • 5. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
    Roa BB, Boyd AA, Volcik K, Richards CS.
    Nat Genet; 1996 Oct 15; 14(2):185-7. PubMed ID: 8841191
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
    Nakahara M, Yokozaki H, Yasui W, Dohi K, Tahara E.
    Cancer Epidemiol Biomarkers Prev; 1997 Dec 15; 6(12):1057-64. PubMed ID: 9419403
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
    Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H.
    Cancer; 2014 Jul 01; 120(13):1960-7. PubMed ID: 24737347
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC.
    Breast Cancer Res Treat; 2004 Nov 01; 88(2):177-86. PubMed ID: 15564800
    [Abstract] [Full Text] [Related]

  • 14. High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.
    Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E.
    Cancer Res; 1999 Mar 01; 59(5):995-8. PubMed ID: 10070953
    [Abstract] [Full Text] [Related]

  • 15. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
    Nat Genet; 1996 May 01; 13(1):126-8. PubMed ID: 8673092
    [Abstract] [Full Text] [Related]

  • 16. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
    Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.
    Nat Genet; 1996 Oct 01; 14(2):188-90. PubMed ID: 8841192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
    Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE.
    Cancer Res; 1996 Dec 01; 56(23):5360-4. PubMed ID: 8968085
    [Abstract] [Full Text] [Related]

  • 20. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.
    Ganguly A, Leahy K, Marshall AM, Dhulipala R, Godmilow L, Ganguly T.
    Genet Test; 1997 Dec 01; 1(2):85-90. PubMed ID: 10464631
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.